DermBiont: Funding, Investors & Team (Oct 2026)
DermBiont is a biotech firm focused on creating skin microbiome treatments for the prevention and treatment of skin disorders. This company operates at the junction of two dynamic fields: dermatology and the microbiome. They utilize naturally existing microbes found on the human skin, which have evolved over a vast period to combat harmful microorganisms like fungi, bacteria, and viruses. Established in 2017, DermBiont is based in Boston, Massachusetts, with an additional office in Emeryville, California.
DermBiont has raised $43.2M across 4 funding rounds on record, the most recent a Series B of $35.2M announced in Oct 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
DermBiont Company Profile and Key Stats
Latest funding round on record: Oct 2023.
DermBiont Funding Rounds
DermBiont raised $800k in an undisclosed round announced in Jan 2022.
8 months later, a Debt Financing of $2.5M was announced in Sep 2022.
6 months later, an undisclosed round of $4.7M was announced in Mar 2023.
7 months later, a Series B of $35.2M was announced in Oct 2023.
DermBiont Founders and Leadership Team
Contact details for the DermBiont team: 1 of 3 have an email address on file.
Start 14-day free trial →DermBiont Funding Compared to Other Biotechnology Startups
DermBiont's latest round of $35.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DermBiont in Biotechnology and Boston
Companies Similar to DermBiont
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
DermBiont Funding FAQs
What does DermBiont do?
DermBiont is a biotech firm focused on creating skin microbiome treatments for the prevention and treatment of skin disorders. This company operates at the junction of two dynamic fields: dermatology and the microbiome. They utilize naturally existing microbes found on the human skin, which have evolved over a vast period to combat harmful microorganisms like fungi, bacteria, and viruses. Established in 2017, DermBiont is based in Boston, Massachusetts, with an additional office in Emeryville, California.
How much funding has DermBiont raised?
DermBiont has raised $43.2M across 4 rounds on record. The most recent is a Series B of $35.2M announced in Oct 2023.
When did DermBiont last raise funding?
DermBiont's most recent funding round on record is a Series B of $35.2M, announced in Oct 2023.
Who founded DermBiont?
FundedIQ lists Nichola Eliovits (Founder), Robert Brucker (Founder) at DermBiont.
Who is the CEO of DermBiont?
Karl Beutner is listed as CEO at DermBiont.
Where is DermBiont headquartered?
DermBiont is based in Boston, Massachusetts, United States.
How many employees does DermBiont have?
DermBiont is in the 11-50 employee band.
How does DermBiont's funding compare to other Biotechnology startups?
DermBiont's latest round of $35.2M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's DermBiont Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DermBiont is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.